Amiti Ventures Joins AION Labs as Strategic Partner

AION Labs partners with Amiti Ventures to drive precision medicine

AION Labs, a venture studio focused on AI and computational science in drug discovery and development, has announced a new strategic partnership with Israeli early-stage venture capital firm Amiti Ventures. The partnership aims to advance healthcare towards more patient-centric precision medicine and bring new treatments to the market. AION Labs, which builds and invests in AI and biology-focused early-stage startup teams, will benefit from the resources and mentorship provided by Amiti Ventures. The venture includes industry giants like AstraZeneca, Merck, Pfizer, and Teva, as well as the Israel Biotech Fund and Amazon Web Services (AWS). The collaboration is powered by BioMed X with the support of the Israeli Government through the Israel Innovation Authority.